首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1653929

抗菌敏感性测试市场规模、份额和成长分析（按产品、类型、方法、应用、最终用户和地区）- 2025-2032 年产业预测

Antimicrobial Susceptibility Testing Market Size, Share, and Growth Analysis, By Product, By Type, By Method, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年02月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年抗生素敏感性测试市场规模价值 44 亿美元，预计将从 2024 年的 46.3 亿美元增长到 2032 年的 69.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.2%。

抗菌药敏测试（AST）市场是医疗保健产业不可或缺的一部分，尤其是在感染疾病和微生物控制领域。随着全球抗生素抗药性细菌的快速增加和感染疾病的增多，对可靠诊断技术的需求日益增加。自动化和先进的分子生物学技术等创新将提高 AST 的准确性和效率。然而，AST 技术高成本、缺乏标准化和程序复杂等挑战可能会阻碍市场成长，尤其是在中低收入地区。儘管存在这些障碍，但市场仍然提供了机会，特别是随着即时诊断和再生医学的进步。预计未来一年美国AST 市场将持续成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司详细信息
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Bio-Rad Laboratories, Inc.（US）
Danaher Corporation（US）
Becton, Dickinson and Company（US）
bioMerieux SA（France）
Roche Diagnostics（Switzerland）
Abbott Laboratories（US）
Bruker Corporation（US）
Merck KGaA（Germany）
Agilent Technologies, Inc.（US）
ConvaTec Group plc（UK）
HiMedia Laboratories Pvt. Ltd.（India）
Liofilchem srl（Italy）
Accelerate Diagnostics, Inc.（US）
Creative Diagnostics（US）
Bio-Rad Laboratories（US）
Synbiosis（UK）
QIAGEN NV（Germany）

结论和建议

简介目录

Product Code: SQMIG35B2120

Antimicrobial Susceptibility Testing Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.63 billion in 2024 to USD 6.94 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The antimicrobial susceptibility testing (AST) market is a vital component of the healthcare industry, especially in managing infectious diseases and microbiology. Driven by the surge in antibiotic-resistant bacteria and the global rise in infectious diseases, there is an increasing demand for reliable diagnostic technologies. Innovations such as automation and advanced molecular methods enhance the accuracy and efficiency of AST. However, challenges such as the high cost of AST technologies, a lack of standardization, and complex procedures may hinder market growth, particularly in middle and low-income regions. Despite these obstacles, the market is presented with opportunities, particularly with the trend towards point-of-care testing and advancements in regenerative medicine. The US AST market is expected to experience sustainable growth in the coming forecast year.

Top-down and bottom-up approaches were used to estimate and validate the size of the Antimicrobial Susceptibility Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Antimicrobial Susceptibility Testing Market Segments Analysis

Global Antimicrobial Susceptibility Testing Market is segmented by Product, Type, Method, Application, End User and region. Based on Product, the market is segmented into Consumables, Lab Instruments and Lab Disposables. Based on Type, the market is segmented into Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing and Antiviral Susceptibility Testing. Based on Method, the market is segmented into Qualitative Methods and Quantitative Methods. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Epidemiology and Other Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Clinical Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Antimicrobial Susceptibility Testing Market

The rise of Antimicrobial Resistance (AMR) poses a significant challenge to global health, prompting health organizations and authorities to emphasize the importance of effective Antimicrobial Susceptibility Testing (AST) to monitor resistance patterns. This testing plays a crucial role in informing treatment choices and promoting the appropriate use of antibiotics. Additionally, the increasing prevalence of infectious diseases, exacerbated by factors such as travel, urbanization, and population growth, necessitates timely diagnosis and treatment. Consequently, this surge in infectious cases fuels the demand for reliable and efficient AST, making it an essential component in the fight against AMR.

Restraints in the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing (AST) market faces several challenges, particularly in middle and low-income countries where there is a significant lack of awareness regarding the advantages of AST. This gap in understanding can hinder its widespread acceptance. Additionally, inadequate training of laboratory personnel on current testing methodologies further impedes the effective implementation of AST. Compounding these issues, the regulatory landscape governing diagnostic tools and solutions can be complex and time-consuming, with stringent requirements potentially delaying the launch of innovative AST technologies. Consequently, these factors may restrict the growth and accessibility of AST in certain regions.

Market Trends of the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing market is witnessing a significant trend toward the adoption of rapid testing techniques that deliver immediate results, transforming the landscape of pathogen detection and treatment decisions. Innovations such as mass spectrometry, molecular diagnostics, and automated systems are being rapidly developed to streamline the testing process, reducing turnaround times from days to mere hours. This shift is particularly impactful in critical care environments, where timely identification of bacterial resistance is vital for improving patient outcomes. As healthcare providers increasingly prioritize speed and accuracy in antimicrobial stewardship, the demand for rapid testing solutions is anticipated to surge, reshaping market dynamics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis
Patent Analysis

Global Antimicrobial Susceptibility Testing Market Size by Product & CAGR (2025-2032)

Market Overview
Consumables
- Culture & Growth Media
- Susceptibility Testing Disks
- Mic Strips
- Susceptibility Testing Plates
Lab Instruments
- Automated Laboratory Instruments
- Molecular Diagnostics Systems
Lab Disposables

Global Antimicrobial Susceptibility Testing Market Size by Type & CAGR (2025-2032)

Market Overview
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Antiviral Susceptibility Testing

Global Antimicrobial Susceptibility Testing Market Size by Method & CAGR (2025-2032)

Market Overview
Qualitative Methods
- Automated Ast
- Disk Diffusion
- Agar Dilution
- Genotypic Method
Quantitative Methods
- ETEST Method
- Broth Macrodilution

Global Antimicrobial Susceptibility Testing Market Size by Application & CAGR (2025-2032)

Market Overview
Clinical Diagnostics
Drug Discovery & Development
Epidemiology
Other Applications

Global Antimicrobial Susceptibility Testing Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals & Diagnostic Centers
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Research Organizations

Global Antimicrobial Susceptibility Testing Market Size & CAGR (2025-2032)

North America (Product, Type, Method, Application, End User)
- US
- Canada
Europe (Product, Type, Method, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Method, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Method, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Method, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConvaTec Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Liofilchem s.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelerate Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synbiosis (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments